One of the most common mistakes in discussions about lavender essential oil is treating all lavender studies as though they are studying the same thing. They are not.

A study using lavender aroma in a hospital room is not the same as a study using diluted lavender oil in massage. A study using lavender oil in a bath is not the same as a study using a standardised oral lavender-oil capsule. Even studies that all use "lavender essential oil" may differ in species, chemical composition, dose, dilution, method of use and duration of exposure.

This matters because the route of use affects both the likely effect and the safety profile.

Lavender aroma and inhalation

Many studies investigate lavender by inhalation, for example with lavender oil placed on a patch, pillow, cotton pad, diffuser, mask or inhalation device. In these studies, the oil is usually being assessed as an aroma exposure.

This type of research is most relevant to questions about relaxation, perceived stress, hospital anxiety, sleep quality or comfort. It does not prove that lavender oil has the same effect when applied to the skin, used in a bath, swallowed, or blended with other oils.

For a consumer essential oil, this is the most relevant category of evidence for cautious claims about atmosphere, relaxation and wellbeing.

Topical lavender oil

Topical studies involve lavender oil being applied to the skin, usually diluted in a carrier oil, cream, gel or other base. These studies raise different questions from inhalation studies, because the oil comes into direct contact with the skin.

Topical use is therefore relevant to skin tolerance, irritation, contact allergy and local effects. It should not be confused with simply smelling lavender. Essential oils are concentrated substances and should not normally be applied neat to the skin, especially on children, sensitive skin, broken skin or inflamed skin.

Lavender massage

Some studies use lavender oil as part of massage. These can be difficult to interpret, because massage itself may reduce stress, pain or muscle tension. If a study compares lavender massage with no treatment, it cannot easily show whether the effect came from the lavender oil, the massage, the human contact, the quiet setting, or all of these together.

The strongest massage studies are those that compare lavender massage with an otherwise identical massage using an unscented carrier oil or another control.

Lavender baths

Bath studies are different again. Warm water, time out, privacy and physical relaxation can all affect how someone feels. If lavender oil is added to a bath, any observed effect may come from the lavender aroma, the skin exposure, the warm bath itself, or the ritual of bathing.

Lavender oil should not be dropped neat into bath water, because essential oil can float on the surface and come into contact with the skin undiluted. It should only be used in a properly diluted or dispersed bath product.

Oral lavender oil and Silexan

A separate body of research concerns Silexan, a proprietary oral lavender-oil preparation used in clinical trials, particularly in studies on anxiety. This evidence is important, but it should not be treated as evidence that ordinary bottled lavender essential oil should be swallowed.

Silexan is a standardised oral preparation with controlled composition, dose and manufacturing standards. That is very different from casual ingestion of essential oil. Ordinary essential oils are concentrated aromatic products and should not be taken internally unless under appropriate professional supervision and supplied in a product specifically intended and regulated for that use.

Why this distinction matters

When reviewing lavender research, the key question is not simply:

"Does lavender oil work?"

The better question is:

"Which lavender preparation was used, by what route, at what dose, in which people, compared with what control, and for what outcome?"

Without those distinctions, it is easy to overstate the evidence. A careful literature review should separate inhalation studies, topical studies, massage studies, bath studies and oral Silexan trials, rather than presenting them as interchangeable proof of the same effect.

Evidence hierarchy

Not all lavender studies carry the same weight. A careful review should give more weight to studies that summarise multiple trials, use proper controls, include enough participants, and clearly describe the oil, dose and method of use.

At the top of the evidence hierarchy are systematic reviews and meta-analyses. These studies search for all relevant research on a question, assess study quality, and, where possible, combine the results statistically. They are useful because they show the overall direction of the evidence rather than relying on a single positive or negative study.

Next are randomised controlled trials, especially those that are blinded, adequately powered and use a clear comparator such as placebo, usual care, unscented oil, or another active treatment. These are particularly valuable where the study clearly distinguishes between inhaled lavender aroma, topical lavender oil, lavender massage, bath use or oral lavender-oil preparations.

Lower down the hierarchy are small pilot studies, uncontrolled studies, case reports, animal studies and laboratory studies. These can be scientifically useful, especially for understanding possible mechanisms, safety issues or antimicrobial activity, but they should not be treated as proof that lavender essential oil produces the same effect in ordinary consumer use.

For this reason, the strongest conclusions on this page are drawn from systematic reviews, meta-analyses and controlled clinical trials. Laboratory, animal and early-stage studies are included where relevant, but they should be understood as supporting or exploratory evidence rather than proof of a consumer health benefit.

Summary of findings

The scientific literature on lavender essential oil is broad, but uneven. Some areas have a relatively developed clinical evidence base, while others remain early-stage or largely laboratory-based.

The strongest human evidence relates to anxiety and stress, particularly studies of standardised oral lavender-oil preparations such as Silexan. These studies are important, but they should be kept separate from ordinary lavender essential oil used by inhalation or on the skin. Evidence for inhaled lavender aroma is generally promising, especially in settings involving stress, clinical procedures, sleep and relaxation, but the studies often differ in design, dose, oil composition and control method.

The evidence for sleep quality is also promising but mixed. Some trials suggest lavender aroma may improve subjective sleep quality, particularly when used as part of a calming evening routine or in clinical settings. However, many sleep studies are small, rely on self-reported outcomes, and often combine lavender with other interventions such as sleep hygiene, massage, bathing or nursing care.

For pain, maternity care and clinical-procedure anxiety, several studies suggest lavender aromatherapy may help reduce perceived discomfort or anxiety in specific settings. These findings are interesting, but they should not be generalised too far. A study in labour, dental treatment, surgery or hospital care does not automatically prove that a consumer lavender oil product will produce the same effect at home.

For skin, wound healing and inflammation, the evidence is more preliminary. Reviews and preclinical studies suggest possible biological activity, but differences in oil composition, dilution, model and outcome make it difficult to draw firm conclusions. Lavender oil should not be presented as a treatment for wounds, burns, eczema, infection or inflammatory skin disease.

For antimicrobial activity, laboratory studies show that lavender essential oil can inhibit some bacteria and fungi under experimental conditions. This is scientifically interesting, but it is not the same as proving that lavender oil works as a disinfectant, antiseptic, antibiotic or infection treatment in real life.

For safety, lavender oil is widely used and generally well tolerated when used appropriately, but it is not risk-free. Possible issues include skin irritation, allergic contact dermatitis, eye irritation, sensitivity to fragrance, accidental ingestion and special considerations for children, pregnancy, breastfeeding, pets and people taking medicines.

The most accurate overall conclusion is that lavender essential oil has a long history of traditional use and a growing scientific literature, particularly around relaxation, stress, anxiety and sleep. The evidence is encouraging in several areas, but it is not uniform, and it depends heavily on the route of use, preparation, dose and study design.

A responsible review should therefore avoid the simple question, "Does lavender oil work?" and instead ask:

Which lavender preparation was used, by what route, at what dose, in which population, compared with what control, and for which outcome?

That is the standard needed to interpret the lavender literature properly.

Sleep and insomnia

Lavender essential oil has a long history of traditional use in evening routines, baths, pillows, aromatherapy and relaxation practices. In scientific terms, however, the sleep evidence needs to be interpreted carefully. Studies differ widely in the form of lavender used, the dose, the route of exposure, the control group, the study population and the outcome measured.

The most cautious conclusion is that lavender essential oil may support subjective sleep quality in some settings, particularly where poor sleep is associated with stress, hospitalisation, anxiety or disrupted routines. It should not be described as a proven treatment for insomnia.

Traditional-use evidence

The European Medicines Agency's Committee on Herbal Medicinal Products concluded that lavender oil medicines may be used, on the basis of long-standing traditional use, for mild symptoms of mental stress and exhaustion and to aid sleep. This is an important regulatory source because it supports lavender's traditional role while also drawing a line between traditional use and definitive clinical proof. The EMA states that clinical studies suggested possible effects on anxiety, stress and insomnia, but that the number of patients per study was too low to establish an effect.

That distinction is useful for this review. Lavender's use in sleep routines is plausible and well established, but the clinical evidence is not strong enough to say that ordinary lavender essential oil treats insomnia.

Systematic reviews and meta-analyses

A 2025 systematic review and meta-analysis of randomised controlled trials found that lavender essential oil intervention had a significant sleep-enhancing effect in adults. However, the authors also stated that the conclusion was limited by the quantity and quality of the included studies and required confirmation in more high-quality trials.

A separate 2025 systematic review focused on older adults with sleep disorders found a predominantly positive effect on sleep quality, but the review was restricted to clinical trials in people aged over 60 and noted substantial heterogeneity. That means it is useful evidence for the elderly population, but it should not automatically be generalised to all consumers or all forms of lavender use.

An earlier systematic review, published in 2012, reviewed lavender and sleep and found the evidence promising but limited. This is still useful historically because many of the later clinical trials build on the same basic question: whether lavender aroma has measurable effects beyond expectation, relaxation setting or sleep hygiene.

Individual clinical studies

Several individual studies suggest that lavender aroma may improve sleep quality, particularly in hospital or care settings. These studies are useful, but they are not all equivalent.

Moeini et al. 2010, ischemic heart disease patients. This study examined lavender aromatherapy in patients with ischemic heart disease and found a statistically significant improvement in sleep-quality scores after lavender aromatherapy compared with control. This is a relevant clinical study, but the population was hospitalised cardiac patients, not the general public using lavender oil at home.

Lytle et al. 2014, intermediate care unit pilot study. This randomised pilot study assessed inhalation of 100% lavender oil in an intermediate care unit, looking at vital signs and perceived sleep quality. It is useful because it involved a defined clinical setting and a clear inhalation intervention, but it was a pilot study and should be treated as preliminary.

Hirokawa et al. 2012, healthy Japanese students. This small study examined lavender aroma exposure in healthy Japanese students. The main reported effect was improvement in sleepiness at awakening, rather than proof of treatment for insomnia. It is best cited as preliminary evidence that nighttime lavender aroma may affect perceived morning sleepiness in healthy people.

Lillehei et al. 2015, college students with self-reported sleep issues. This randomised controlled trial tested inhaled lavender alongside sleep-hygiene advice. Lavender plus sleep hygiene improved sleep quality, while sleep hygiene alone also improved sleep to a lesser degree. This is one of the more relevant consumer-style studies, but the result should not be attributed to lavender alone because sleep-hygiene advice was part of the intervention.

Karadag et al. 2017, coronary artery disease patients. This study found that lavender essential oil increased sleep quality and reduced anxiety in patients with coronary artery disease. It supports the pattern seen in other hospital studies, but it remains a specific clinical population rather than general insomnia evidence.

How strong is the sleep evidence?

Overall, the sleep literature is encouraging but uneven. The strongest recent reviews suggest a positive effect on sleep quality, but they also emphasise limitations in study quality, sample size, heterogeneity and methodology. Many studies rely on subjective sleep scales rather than objective measures such as polysomnography or actigraphy.

Anxiety and stress

Lavender essential oil has been studied more often for anxiety and stress than almost any other essential oil. The evidence is interesting, but it needs to be read carefully. Not all "lavender anxiety" studies are studying the same thing.

Some research looks at inhaled lavender aroma, where the oil is placed on a cotton pad, pillow, mask, patch or diffuser. Some studies look at lavender massage, where touch and relaxation may contribute to the effect. A separate and stronger body of clinical research looks at Silexan, a standardised oral lavender-oil preparation used in anxiety trials. These categories should not be treated as interchangeable.

The most accurate conclusion is that lavender has a meaningful body of research relating to anxiety and stress, but the strength of the evidence depends heavily on the route of use, preparation, dose, study design and population.

Traditional use for mild stress

The European Medicines Agency's herbal committee concluded that lavender oil may be used, on the basis of long-standing traditional use, for the relief of mild symptoms of mental stress and exhaustion and to aid sleep. This is an important regulatory source because it recognises lavender's traditional role while also making clear that this is based on traditional use rather than definitive proof from large clinical trials.

For a consumer essential-oil product, this distinction matters. Lavender can fairly be discussed in relation to relaxation, calm, atmosphere and mild stress, but ordinary lavender essential oil should not be presented as a treatment for anxiety disorders, panic attacks, depression or other medical conditions. UK advertising guidance treats claims to treat or help with medical conditions as medicinal claims requiring robust substantiation and, in many cases, appropriate product authorisation.

Inhaled lavender aroma

Inhalation is the most relevant category for ordinary lavender essential oil used in the home. In these studies, participants usually inhale lavender aroma from a patch, cotton pad, pillow, mask, diffuser or similar device. The outcome is commonly measured using self-reported anxiety scales, sometimes alongside physiological measures such as heart rate or blood pressure.

A 2023 systematic review of lavender essential oil inhalation included 11 clinical studies with 972 participants. Ten of those studies reported significantly reduced anxiety after lavender inhalation, although the authors still called for further research because methods, study groups and designs varied.

This supports a cautious conclusion: inhaled lavender aroma may help reduce self-reported anxiety in some settings, especially short-term or situational anxiety. It does not prove that lavender essential oil treats anxiety disorders.

Lavender massage

Lavender massage studies need to be interpreted separately. Massage itself may reduce anxiety, pain or tension through touch, time, attention, slowed breathing and the therapeutic setting. If a study compares lavender massage with no treatment, it cannot easily prove whether any improvement came from the lavender oil, the massage, or both.

A 2019 systematic review and meta-analysis found that lavender administered through massage appeared effective for anxiety, but the authors noted that the available studies could not determine whether the effect was specifically due to lavender. The same review found stronger evidence for oral lavender oil, while inhalation studies showed only an indication of benefit because of heterogeneity.

For this reason, lavender massage research is best described as evidence for an aromatherapy massage intervention, not as direct proof that lavender oil alone reduces anxiety.

Oral lavender oil and Silexan

The strongest clinical evidence in the anxiety literature relates to Silexan, a proprietary oral lavender-oil preparation. Silexan has been studied in randomised clinical trials and meta-analyses involving subthreshold anxiety, generalised anxiety disorder and mixed anxiety and depression.

A 2023 meta-analysis concluded that Silexan showed significant anxiolytic effects in subthreshold anxiety, generalised anxiety disorder and mixed anxiety and depression.

This is important evidence, but it should not be confused with ordinary bottled lavender essential oil. Silexan is a standardised oral preparation with controlled composition and dose. These findings should not be extrapolated to casual ingestion of essential oil, and ordinary lavender essential oil should not be swallowed unless supplied and regulated specifically for that use.

Overall interpretation

The anxiety and stress literature is best understood in layers.

The strongest evidence is for standardised oral lavender-oil preparations such as Silexan. Inhaled lavender aroma has shown promising results in several clinical studies, especially for short-term anxiety in defined settings, but the evidence is more variable. Lavender massage studies are also encouraging, but they are difficult to separate from the effects of massage itself.

Mood and depression-related studies

Lavender essential oil has been studied not only for anxiety and sleep, but also for mood and depression-related outcomes. This area of the literature is interesting, but it is less developed than the anxiety literature and should be interpreted with particular care.

The first distinction is between low mood, self-reported depressive symptoms, and clinical depression. These are not the same thing. A study showing that lavender aroma improved mood in healthy volunteers does not prove that lavender oil treats depression. Similarly, studies in postpartum women, older adults, hospital patients or people with anxiety-related low mood should not be generalised too far.

Systematic reviews and meta-analyses

A 2021 systematic review and meta-analysis examined randomised controlled trials on lavender aromatherapy and its effects on anxiety, depression and physiological parameters. The review concluded that lavender aromatherapy showed effects in reducing anxiety and depression, but also noted that randomised controlled trials specifically focused on depression were scarce and that future trials were needed.

That is the key point for this section. The depression evidence is promising, but thinner than the anxiety evidence. It should be described as an emerging area of research, not as proof that lavender oil is an antidepressant.

A separate 2023 meta-analysis of aromatherapy for depression found a moderate overall effect size for reducing depressive symptoms across randomised controlled trials. However, that review was not limited to lavender essential oil alone. It included aromatherapy more generally, including lavender and other single essential oils.

This means the evidence supports interest in aromatherapy for depressive symptoms, but it does not allow a simple claim that lavender essential oil by itself treats depression.

Lavender aromatherapy and depressive symptoms

A systematic review of aromatherapy with lavender essential oil for depression found that some studies reported positive effects, while others did not. The authors suggested that lavender aromatherapy may be useful as a complementary approach for mild to moderate depression, but the mixed results mean the conclusion should be treated cautiously.

For a literature review, that is worth including. For a product page, however, the wording needs to be careful. It would be inappropriate to say that lavender oil "treats depression" or "relieves depression".

Mood studies in healthy volunteers

Some research has looked at mood change in healthy individuals rather than patients with depression. One 2020 preliminary study reported that lavender oil reduced depressive mood in healthy individuals and also explored possible biological mechanisms using isolated oxytocin neurons from mice.

This type of study is useful because it suggests possible mood-related effects and mechanisms. However, it should not be overstated. Healthy-volunteer mood studies are not the same as clinical trials in people diagnosed with depression.

Postpartum mood studies

Several studies have examined lavender aromatherapy in the postpartum period. One study of lavender oil aroma in the early hours after childbirth reported improvements in pain, fatigue, distress and maternal mood. Another study investigated lavender scent inhalation in relation to postpartum stress, anxiety and depression.

A 2023 systematic review and meta-analysis examined aromatherapy for postpartum depression, indicating that this has become a specific area of research interest.

These studies are relevant, but postpartum mental health is a specialist clinical area. Lavender aromatherapy should not be presented as a treatment for postpartum depression. Anyone experiencing persistent low mood, anxiety, intrusive thoughts, loss of interest, hopelessness or difficulty bonding after childbirth should seek professional support.

Silexan and mixed anxiety-depression

A separate category of evidence concerns Silexan, a standardised oral lavender-oil preparation used in clinical trials. One randomised trial examined Silexan in mixed anxiety and depression and reported better overall clinical outcomes compared with placebo. A 2023 meta-analysis also reported significant anxiolytic effects of Silexan in subthreshold anxiety, generalised anxiety disorder and mixed anxiety and depression.

This evidence is important, but it should be clearly separated from ordinary lavender essential oil. Silexan is a controlled oral preparation used in clinical research. It is not the same as inhaling lavender aroma, using lavender oil in massage, or swallowing ordinary essential oil.

Overall interpretation

The mood and depression literature is promising but still limited. Lavender aromatherapy has been studied in relation to mood, depressive symptoms, postpartum wellbeing and mixed anxiety-depression. Some reviews report positive findings, but the evidence is not strong enough to claim that ordinary lavender essential oil treats depression.

Pain, surgery and clinical-procedure anxiety

Lavender aromatherapy has been studied in a range of clinical settings, including surgery, postoperative recovery, dentistry, needle-related procedures, labour, caesarean delivery and interventional pain procedures. This is one of the more active areas of lavender research, but it needs careful interpretation.

Most of these studies examine lavender as a complementary intervention in a controlled clinical setting. They do not show that lavender essential oil should replace anaesthesia, analgesics, sedatives, antiseptics, wound care or medical treatment.

Preoperative anxiety

Preoperative anxiety is common before surgery. Several studies have investigated whether lavender aromatherapy can reduce anxiety in patients waiting for surgical procedures.

A 2024 systematic review and meta-analysis examined lavender oil application for preoperative anxiety in patients scheduled for surgical procedures. The review was designed specifically to assess lavender oil's effect on anxiety before surgery. A broader systematic review and meta-analysis of aromatherapy for preoperative anxiety in adults concluded that aromatherapy was effective in reducing preoperative anxiety, while also calling for better-designed randomised controlled trials across a wider range of surgical types and countries.

This supports a cautious statement that lavender aromatherapy may reduce preoperative anxiety in some clinical settings. It does not justify saying that lavender oil replaces sedatives, anaesthetic assessment or clinical anxiety management.

Postoperative pain

A 2025 systematic review of randomised controlled trials examined inhaled lavender aromatherapy for postoperative pain management in adults. It included 15 studies, most published from 2015 onwards, and found that inhaled lavender aromatherapy significantly reduced postoperative pain levels compared with controls. However, the evidence was insufficient to confirm whether lavender reduced postoperative analgesic consumption.

This is a useful and relatively recent evidence source, but the conclusion should be kept precise. Lower pain scores are not the same as reduced need for pain medication, and the review itself calls for further high-quality randomised trials.

Caesarean delivery and postoperative recovery

Lavender aromatherapy has also been studied after caesarean delivery. A 2024 randomised controlled trial reported that lavender essential oil aromatherapy was effective in reducing pain and anxiety after caesarean delivery without reported adverse effects. Earlier caesarean-related research also suggested reductions in pain after surgery when lavender was used by inhalation.

These findings are relevant, but caesarean recovery is a medical and postoperative context. Lavender should only be described as a complementary aromatherapy intervention studied in clinical settings.

Labour pain and anxiety

Aromatherapy has been studied during labour, where anxiety, pain and stress can interact. A 2020 systematic review examined aromatherapy for the management of labour pain and anxiety and found that lavender was among the commonly studied oils. A 2021 trial on aromatherapy during the first stage of labour found that aromatherapy significantly decreased pain and anxiety.

This is an important area, but it requires especially cautious wording. Labour and pregnancy are not suitable contexts for casual essential-oil claims. Any use during pregnancy, labour or postpartum recovery should be discussed with a midwife, doctor or appropriately qualified healthcare professional.

Dental anxiety and dental pain

Dental anxiety is another area where lavender has been studied. A 2021 systematic review on aromatherapy for dental anxiety concluded that aromatherapy was more effective than negative control conditions and had comparable effects to some other approaches studied.

Individual studies have also reported reductions in dental anxiety with lavender scent. A 2010 study found that lavender scent reduced state anxiety in dental patients, although it did not affect anxiety about future dental visits. A 2020 crossover randomised clinical trial investigated lavender aromatherapy during dental treatment and measured anxiety and pain outcomes.

This evidence is useful because it shows a plausible short-term effect in a defined setting. However, the outcome is usually state anxiety around a procedure, not a long-term anxiety disorder.

Needle-related procedures

Needle-related procedures, including cannulation, injections, catheter placement and haemodialysis access, are another area of research. A 2025 systematic review and meta-analysis found that aromatherapy significantly reduced pain and anxiety in adults undergoing needle-related invasive procedures compared with placebo or conventional interventions.

This review was about aromatherapy broadly, not necessarily lavender alone in every study. It is therefore best used to support the idea that aromatherapy may have a role in procedural comfort, rather than as proof that lavender oil itself works in every needle-related context.

Interventional spine procedures

Lavender aromatherapy has also been tested before interventional pain procedures. A 2021 study reported that lavender-based aromatherapy reduced preprocedural anxiety before interventional spine procedures. Another study investigated whether inhaled lavender essential oil reduced pain and anxiety associated with interventional spine procedures such as lumbar epidural steroid injections and medial branch blocks.

This is a useful example because it shows lavender being studied as a non-sedating adjunct in a specific medical environment. It does not mean lavender oil should be used as a stand-alone treatment for back pain or procedural pain.

Overall interpretation

The clinical-procedure literature is one of the more promising areas for lavender aromatherapy, especially for short-term anxiety and perceived pain around defined procedures. The evidence is strongest when lavender is used as a brief inhaled intervention in a controlled setting and measured against a comparator.

However, the limitations are important. Studies vary in oil composition, dose, inhalation time, control group, blinding, surgical type, pain measurement and clinical population. Some studies measure anxiety, some measure pain, some measure analgesic use, and some measure patient satisfaction or vital signs. These outcomes should not be treated as interchangeable.

Pregnancy, labour and postpartum studies

Lavender aromatherapy has been studied in pregnancy, labour, caesarean recovery and the postpartum period. This area of the literature is clinically interesting, but it requires careful interpretation because pregnancy, birth and early postpartum recovery are specialist healthcare contexts. Most studies examine lavender as a complementary intervention alongside ordinary maternity care, rather than as a stand-alone treatment.

Recent reviews suggest that aromatherapy may have measurable effects on some pregnancy-related symptoms. A 2025 systematic review of aromatherapy in pregnant women concluded that aromatherapy appears to be a potentially useful and safe option for some gestational symptoms, with lavender among the oils associated with improved sleep quality. The authors nevertheless called for larger, higher-quality studies because the evidence base remains heterogeneous.

A 2024 review focused specifically on lavender essential oil in pregnancy examined studies on anxiety, stress and sleep quality. The review reported generally positive findings across the selected studies, including reductions in anxiety or stress and improvements in sleep-related outcomes. However, the review included only six articles, meaning that the evidence should be treated as promising but limited rather than definitive.

Labour pain and anxiety have also been studied. A systematic review and meta-analysis of aromatherapy for labour pain found that aromatherapy had a beneficial effect on labour-pain outcomes across the included studies. Lavender was one of the oils commonly represented in this area of research, although not every aromatherapy trial used lavender alone. The main limitation is that studies vary in oil type, route of administration, labour stage, comparator and outcome measurement.

Post-caesarean recovery is another clinical setting in which lavender has been investigated. A 2024 randomised controlled trial found that lavender essential oil aromatherapy reduced pain and anxiety after caesarean delivery, with no adverse effects reported in that study. This is relevant evidence for complementary aromatherapy in a supervised postoperative setting, but it does not mean lavender oil should be treated as a replacement for postoperative analgesia or clinical care.

Lavender oil aroma has also been studied in the early postpartum period after vaginal birth. A 2017 randomised clinical trial in primiparous mothers reported that lavender oil aromatherapy starting in the first hours after birth was associated with improved physical and mood status compared with a non-aromatic control. The outcomes included maternal pain, fatigue, distress and mood. The trial is useful because it focused on the immediate postpartum period, but it was still a relatively small clinical study.

A further postpartum trial investigated lavender scent inhalation over four weeks after childbirth. In that study, 140 women were divided into aromatherapy and control groups, with the aromatherapy group inhaling three drops of lavender essential oil every eight hours for four weeks. The authors reported lower stress, anxiety and depression scores in the lavender group at follow-up points after delivery. This is an important study in the postpartum literature, although the language of "prevention" should be handled cautiously because postpartum depression is a medical condition requiring appropriate clinical assessment and support.

Overall, the maternity literature suggests that lavender aromatherapy may have a role as a complementary intervention for anxiety, stress, sleep quality, labour discomfort, caesarean recovery and early postpartum wellbeing. The evidence is most appropriately understood as context-specific clinical research, not as general advice for unsupervised essential-oil use in pregnancy, labour or postpartum recovery. Individual circumstances, pregnancy complications, asthma, allergies, medication use and breastfeeding status all affect suitability.

Skin, wound healing and inflammation

Lavender essential oil has been studied for skin-related effects, including wound healing, inflammation, collagen expression and tissue remodelling. This area of research is biologically plausible because lavender oil contains compounds such as linalool and linalyl acetate, but the current evidence is still much stronger at the laboratory, animal and early clinical level than at the level of established human treatment.

A 2020 review of lavender essential oil and wound healing identified 20 relevant studies after screening, including human clinical trials, animal studies, in vitro studies and previous reviews. The review found that wounds treated with lavender essential oil showed a faster rate of healing, increased collagen expression and enhanced activity of proteins involved in tissue remodelling. The authors also emphasised the need for standardisation of lavender oil composition and further high-quality studies.

Animal research provides some mechanistic support. A 2016 experimental study reported that lavender oil promoted wound healing in the early phase by accelerating granulation-tissue formation, collagen replacement, tissue remodelling and wound contraction. These findings help explain why lavender oil is of interest in wound-healing research, but animal wound models cannot be treated as direct evidence that ordinary lavender essential oil should be applied to human wounds.

Other work has explored lavender oil in more complex formulations. A 2020 study of a nanoemulsion containing lavender essential oil and licorice extract reported improved wound-healing outcomes, including increased collagen deposition and accelerated re-epithelialisation. This is scientifically relevant, but it relates to a specific formulated product rather than lavender essential oil used alone.

Lavender essential oil has also been studied for anti-inflammatory activity. A 2021 in vitro study found that lavender essential oil extracted at the beginning of the flowering period inhibited the synthesis of several pro-inflammatory cytokines, including IL-6 and IL-8, in the model used. This supports the idea that lavender oil can have measurable biological activity in inflammatory pathways, but in vitro cytokine studies do not establish clinical efficacy for inflammatory skin conditions.

A 2023 scoping review of Lavandula angustifolia essential oil in adult healthcare found that most studies focused on pain and anxiety, while relatively few examined anti-psoriatic, wound-healing or other skin-specific applications. The review also noted that limited work had addressed safe quantities for human treatment. This is important because topical use depends on dilution, formulation, skin condition and individual sensitivity.

Safety is an important part of the skin literature. A 2019 review of contact allergy and allergic contact dermatitis caused by lavender concluded that lavender is an uncommon cause of allergic contact dermatitis, but still important because exposure through personal care products and essential oils is widespread. This means that topical use should not be assumed to be risk-free, particularly in people with sensitive skin, eczema, fragrance allergy or a history of contact dermatitis.

Taken together, the skin and wound-healing literature suggests that lavender essential oil has promising biological activity, particularly in relation to collagen expression, tissue remodelling and inflammatory pathways. However, the evidence does not justify presenting ordinary lavender essential oil as a treatment for wounds, burns, eczema, psoriasis, infection or inflammatory skin disease. The strongest conclusion is that lavender oil remains an active area of dermatological and wound-healing research, with more standardised human studies needed.

Antimicrobial and MRSA studies

Lavender essential oil has been investigated for antimicrobial activity against bacteria and fungi, including antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus, or MRSA. This area of the literature is scientifically important, but it is also one of the easiest to overstate. Antimicrobial activity in a laboratory test does not necessarily translate into safe or effective infection treatment in humans.

A 2023 systematic review examined the antibacterial effectiveness of lavender essential oil against Staphylococcus aureus and MRSA. The review searched studies published between 2002 and 2022 and included 23 studies. These studies used different experimental methods and tested lavender oil either alone or in combination with other antibacterial substances.

The review found mixed results. Some studies reported significant antibacterial activity, while others found minimal or negligible effects. The authors also noted that lavender oil may show greater potential when used in combination with other antibacterial agents, but the overall evidence remains largely laboratory-based.

The limits of this evidence are important. In vitro studies often use agar diffusion tests, minimum inhibitory concentration assays or other controlled laboratory methods. These tests can show whether lavender oil inhibits microbial growth under particular experimental conditions, but they do not reproduce the complexity of human skin, wounds, infection, immune response, contact time, product formulation or safe topical concentration.

Oil chemistry is another important variable. Lavender essential oil is not a single uniform substance. Its composition varies with species, cultivar, growing conditions, harvest timing, distillation method, storage and age. This makes antimicrobial findings difficult to generalise unless the chemical profile of the oil is clearly reported.

The MRSA literature is therefore best understood as evidence of biological potential rather than clinical proof. Lavender essential oil may inhibit some organisms under laboratory conditions, and this supports continued research into its antimicrobial properties. However, current evidence does not support using ordinary lavender essential oil as an antibiotic, antiseptic, disinfectant, wound treatment or substitute for medical care.

Overall, the antimicrobial literature shows that lavender essential oil has measurable activity in some laboratory settings, including against S. aureus and MRSA, but the findings are inconsistent and method-dependent. Further research would need to establish standardised oil chemistry, clinically relevant concentrations, safety, formulation, contact time and real-world effectiveness before stronger conclusions could be drawn.

Mechanisms: linalool, linalyl acetate and CNS targets

Lavender essential oil is a complex natural mixture rather than a single active ingredient. Its biological effects cannot be attributed to one compound alone, but much of the mechanistic literature focuses on two major constituents: linalool and linalyl acetate. These compounds are commonly present in high-quality Lavandula angustifolia essential oil and are also prominent in Silexan, the standardised oral lavender-oil preparation used in many clinical anxiety studies. One analysis of Silexan reported approximately 36.8% linalool and 34.2% linalyl acetate, alongside smaller amounts of lavandulol, lavandulyl acetate, borneol, 1,8-cineole and camphor.

The central nervous system mechanisms proposed for lavender oil are not fully settled. However, laboratory and preclinical studies suggest several plausible pathways, including effects on neurotransmitter systems, ion channels and stress-related signalling. These findings help explain why lavender oil has been studied in relation to anxiety, stress, sleep and pain, but they should not be treated as proof that ordinary lavender essential oil has a predictable clinical effect in every context.

One important mechanistic study, published in Frontiers in Pharmacology in 2017, examined lavender essential oil on central nervous system targets. The authors reported that lavender oil interacted with NMDA receptor activity, serotonin transporter binding and neurotoxicity induced by hydrogen peroxide in their experimental models. They concluded that lavender oil may exert pharmacological properties through modulation of the NMDA receptor, the serotonin transporter and neuroprotective pathways.

The NMDA receptor is involved in excitatory neurotransmission, learning, memory and stress-related neural activity. The serotonin transporter is involved in regulating serotonin availability in the nervous system. Findings involving these targets are scientifically relevant because they provide possible biological explanations for lavender's observed effects in some anxiety and mood studies. However, receptor and transporter findings in laboratory models are not the same as clinical proof in humans.

Another major proposed mechanism concerns voltage-operated calcium channels. A 2013 pharmacological study reported that lavender oil reduced calcium influx through several types of voltage-operated calcium channels, including N-type, P/Q-type and T-type channels. The authors suggested that this mechanism may contribute to lavender oil's anxiolytic properties.

This is relevant because calcium-channel modulation is one of the proposed explanations for Silexan's clinical effects in anxiety trials. Reviews of oral lavender oil in anxiety have also discussed linalool and linalyl acetate as important contributors to possible anxiolytic activity, while making clear that Silexan is a specific standardised oral preparation rather than ordinary bottled essential oil.

Linalool itself has attracted particular scientific interest. Preclinical studies have reported anxiolytic-like effects of linalool in animal models, and human experimental studies have investigated its stress-related effects. Linalyl acetate is also considered important, although it may act partly through metabolism or interaction with other constituents. The available evidence suggests that lavender oil's effects are likely to result from a combination of compounds rather than from a single isolated molecule.

Inhalation adds another layer of complexity. When lavender aroma is inhaled, volatile compounds reach the olfactory system, which is closely linked to brain regions involved in emotion, memory and arousal. Some compounds may also be absorbed through the respiratory tract. This means that inhaled lavender aroma may involve both sensory pathways and pharmacological pathways, although their relative importance is still debated.

The mechanistic literature therefore supports biological plausibility. Lavender oil contains compounds with measurable effects on nervous-system targets, including serotonin-related pathways, glutamate-related pathways and calcium-channel activity. These findings are consistent with the clinical interest in lavender for anxiety, stress, sleep and procedural discomfort.

However, mechanism studies should be interpreted carefully. A compound interacting with a receptor, transporter or ion channel does not automatically establish a therapeutic effect in real-world use. Human outcomes depend on dose, route of administration, oil chemistry, exposure time, absorption, study population and comparator. The strongest mechanistic conclusion is that lavender essential oil has plausible central nervous system activity, but the clinical significance of that activity depends on the preparation and context in which it is used.

Safety, allergy, children, pregnancy and ingestion

Lavender essential oil is widely used in aromatherapy, perfumery, cosmetics and traditional herbal medicine. It is generally considered one of the milder essential oils when used appropriately, but it is still a concentrated chemical mixture and should not be treated as risk-free.

Safety depends on route of use, dose, dilution, exposure time, age, pregnancy or breastfeeding status, skin condition, allergies, medication use and whether the oil is inhaled, applied to the skin, used in a bath or swallowed. The safety literature is therefore an essential part of any serious review.

The European Medicines Agency's herbal summary reported no major safety concerns at the time of assessment for lavender oil medicines, with only few and mild side effects reported in studies and very rare cases of allergic reactions. The EMA also notes that people with open wounds, skin problems, high fever, severe infections or severe heart and circulation problems should not have full baths with lavender oil.

Skin irritation and contact allergy

Topical use is one of the main safety issues. Lavender oil is often described as gentle, but essential oils can irritate the skin, especially when used undiluted or on sensitive, damaged or inflamed skin. Oxidation of essential oils during storage may also increase sensitisation risk, particularly if bottles are old, repeatedly opened, exposed to light or stored warm.

A 2019 review of contact allergy and allergic contact dermatitis caused by lavender concluded that lavender is an uncommon cause of allergic contact dermatitis, but it remains important because exposure is widespread through personal care products and essential oils.

Allergic contact dermatitis is a delayed immune reaction. It may appear as redness, itching, eczema-like rash, swelling or irritation after exposure. It is different from simple irritation, and once sensitisation occurs, even small future exposures may trigger symptoms.

Dermatology guidance on essential oils more broadly recognises essential oils as potential causes of allergic contact dermatitis. This supports a cautious approach to topical use, especially in people with eczema, fragrance allergy, sensitive skin or a history of contact dermatitis.

Children and endocrine-disruption debate

Lavender oil use around children has received attention because of case reports suggesting a possible association between repeated exposure to lavender or tea tree oil products and prepubertal breast development. This has led to debate about whether some essential-oil constituents may have weak endocrine activity.

The evidence is mixed. Earlier concern was based largely on case reports and laboratory findings, which are useful for generating hypotheses but cannot establish population-level risk. A later epidemiological study published in 2022 found that children regularly exposed to lavender or tea tree essential oils had the same risk of endocrine disorders as children who were not exposed.

This does not prove that repeated essential-oil exposure in children is entirely risk-free. It does, however, show that the evidence is more nuanced than simple claims that lavender oil "causes hormonal problems". The most balanced interpretation is that the endocrine-disruption question remains debated, with limited human evidence and no clear population-level signal in the later study.

Children also require caution for more general reasons. Their skin is thinner, their body weight is lower, and accidental ingestion is a greater risk. Essential oils should be stored securely and used sparingly around babies and children, particularly where there is asthma, eczema, fragrance sensitivity or respiratory disease. General essential-oil safety guidance from Johns Hopkins Medicine emphasises that essential oils should be used carefully around children and that parents should consider age, dilution and route of exposure.

Pregnancy and breastfeeding

Pregnancy and breastfeeding are special safety contexts. The existence of maternity aromatherapy studies does not mean that all lavender oil use is automatically suitable for all pregnant or breastfeeding women.

UKTIS notes that topical exposure to an essential oil during pregnancy would not usually be regarded as medical grounds for pregnancy termination or additional fetal monitoring, while also emphasising individual risk assessment.

The Medicines in Pregnancy service gives particularly clear practical safety advice: undiluted essential oils are highly toxic and should not be swallowed during pregnancy or at any other time, and undiluted oils should not be applied directly to the skin.

NHS breastfeeding guidance also notes that not enough is known about herbal remedies to guarantee that they are safe while breastfeeding, and advises speaking to a GP or pharmacist before taking them.

The safest interpretation is that lavender aromatherapy may have been studied in pregnancy, labour and postpartum settings, but individual suitability depends on the person, pregnancy stage, health history, allergies, medication use and the way the oil is used.

Ingestion and oral lavender products

Ingestion is one of the most important distinctions in the lavender literature. Clinical studies of oral lavender oil usually involve a specific, standardised product such as Silexan. These studies should not be interpreted as evidence that ordinary essential oil from a bottle should be swallowed.

Essential oils are concentrated substances. Poison Control warns that essential oils can cause serious poisoning when misused, and that some can be poisonous if swallowed or absorbed through the skin. It also notes the risk of aspiration, where oil enters the lungs during swallowing or choking and can cause pneumonia.

The Royal Children's Hospital clinical guideline on essential-oil poisoning notes that toxicity depends on the dose and the essential oil ingested, and lists lavender among common household essential oils involved in poisoning presentations.

This distinction should be made repeatedly in any serious lavender-oil review. Silexan is a standardised oral preparation used in clinical trials. Ordinary lavender essential oil sold for aromatherapy or cosmetic use is not the same product and should not be swallowed unless supplied in a product specifically intended, labelled and regulated for internal use.

Drug interactions and vulnerable groups

Herbal and complementary products can interact with medicines or create additional risks in vulnerable groups. NHS guidance on herbal medicines notes that herbal products can cause side effects, interact with other medicines and may not be suitable for everyone. It advises looking for a Traditional Herbal Registration mark where a product is being used as a herbal medicine.

This is relevant to lavender because some of the strongest clinical evidence concerns oral lavender-oil preparations, while ordinary consumer essential oils are often sold for aroma, cosmetic or household use. The regulatory category and intended route of use matter.

People taking sedatives, antidepressants, anti-anxiety medicines, epilepsy medicines or multiple regular medicines should be particularly cautious about oral herbal preparations unless advised by a healthcare professional. People with asthma, fragrance sensitivity, epilepsy, severe allergies, complex medical conditions, pregnancy or breastfeeding should also treat essential oils cautiously.

Overall safety interpretation

The safety literature supports a balanced conclusion. Lavender essential oil has a long history of use and is generally well tolerated when used appropriately, especially by inhalation or in properly diluted topical products. However, allergic contact dermatitis, irritation, accidental poisoning, inappropriate ingestion and unsuitable use in vulnerable groups are real safety considerations.

Regulatory note: why this page is educational, not medical advice

This page is a literature review. It summarises published research on lavender essential oil, lavender aromatherapy, oral lavender-oil preparations and related clinical or laboratory studies. It is intended to help readers understand the scientific evidence, its strengths and its limitations.

Scottish Lavender Oils does not sell lavender essential oil as a medicine. Nothing on this page should be read as a claim that our lavender essential oil, or any ordinary consumer essential oil, can diagnose, treat, prevent or cure disease.

This distinction matters because lavender studies use very different interventions. Some use inhaled lavender aroma. Some use diluted topical oil. Some use aromatherapy massage. Some use lavender in a bath or hospital setting. Some use Silexan, a standardised oral lavender-oil preparation studied in clinical trials. These are not interchangeable.

In the UK, medicinal claims for aromatherapy products are not permitted unless the product is a licensed medicine. The ASA and CAP guidance is clear that objective health claims need robust evidence, and that claims to treat medical conditions may be treated as medicinal claims.

Traditional herbal medicinal products are subject to a separate regulatory route. The MHRA states that a Traditional Herbal Registration is required before a traditional herbal medicinal product can be marketed in the UK. This is different from selling an essential oil for aroma, cosmetic, craft or general wellbeing use.

The European Medicines Agency's herbal committee has concluded that lavender oil medicines may be used, on the basis of long-standing traditional use, for mild symptoms of mental stress and exhaustion and to aid sleep. However, that conclusion relates to herbal medicinal products and traditional-use assessment, not to a blanket claim that any lavender essential oil product treats anxiety, insomnia or disease.

Readers should also be aware that "natural" does not mean risk-free. NHS guidance notes that herbal medicines can cause side effects, interact with other medicines and may not be suitable for everyone.

This page should therefore be read as an evidence review, not as medical advice. Anyone who is pregnant, breastfeeding, taking medication, buying for a child, managing a medical condition, experiencing anxiety, depression, insomnia, infection, pain, skin disease or any other health concern should seek advice from a doctor, pharmacist, midwife or other appropriately qualified healthcare professional.

Full reference list

Regulatory and official guidance

1. Advertising Standards Authority and CAP. Health: Aromatherapy. Guidance on aromatherapy claims, including the restriction on medicinal claims for unlicensed aromatherapy products. asa.org.uk
2. Advertising Standards Authority and CAP. Healthcare: Medicinal Claims. Guidance defining medicinal claims as claims that a product can diagnose, treat or prevent disease, injury, ailment or adverse condition. asa.org.uk
3. Medicines and Healthcare products Regulatory Agency. Apply for a Traditional Herbal Registration. UK guidance on when a traditional herbal medicinal product requires registration. gov.uk
4. European Medicines Agency, Committee on Herbal Medicinal Products. Lavandulae aetheroleum, Herbal Medicinal Product. EMA summary of traditional medicinal use of lavender oil for mild mental stress, exhaustion and sleep support. ema.europa.eu
5. NHS. Herbal medicines. General NHS guidance on herbal medicines, side effects, interactions and suitability. nhs.uk

Evidence overviews, anxiety and Silexan

6. Donelli D., Antonelli M., Bellinazzi C., Gensini G., Firenzuoli F. Effects of lavender on anxiety: a systematic review and meta-analysis. Phytomedicine. 2019. pubmed
7. Yoo O., Park S-A. Anxiety-reducing effects of lavender essential oil inhalation: a systematic review. Healthcare. 2023. pubmed
8. Dold M. et al. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomised placebo-controlled trials. 2023. pubmed
9. Yap W.S. et al. Efficacy and safety of lavender essential oil capsules among patients suffering from anxiety disorders: a network meta-analysis. Scientific Reports. 2019. nature.com
10. National Center for Complementary and Integrative Health. Lavender: Usefulness and Safety. nccih.nih.gov

Sleep and insomnia-related studies

11. Shen H., Zhang L-J., Zhu W-Y. The sleep-enhancing effect of lavender essential oil in adults: a systematic review and meta-analysis. Holistic Nursing Practice. 2025. pubmed
12. Her J., Cho M-K. Effect of aromatherapy on sleep quality of adults and elderly people: a systematic literature review and meta-analysis. 2021. sciencedirect
13. Moeini M. et al. Effect of aromatherapy on the quality of sleep in ischemic heart disease patients. 2010. pubmed
14. Lytle J., Mwatha C., Davis K.K. Effect of lavender aromatherapy on vital signs and perceived quality of sleep in the intermediate care unit: a pilot study. 2014. pubmed
15. Hirokawa K., Nishimoto T., Taniguchi T. Effects of lavender aroma on sleep quality in healthy Japanese students. 2012. pubmed
16. Lillehei A.S. et al. Effect of inhaled lavender and sleep hygiene on self-reported sleep issues: a randomised controlled trial. 2015. pubmed

Mood and depression-related studies

17. Kim M. et al. Effects of lavender on anxiety, depression and physiological parameters: systematic review and meta-analysis. Asian Nursing Research. 2021. asian-nursingresearch.com
18. Jafari-Koulaee A. et al. A systematic review of the effects of aromatherapy with lavender essential oil on depression. 2020. pmc
19. Ogata K. et al. Lavender oil reduces depressive mood in healthy individuals and enhances oxytocin neuronal activation in mice. 2020. pmc
20. Kasper S. et al. Silexan in anxiety, depression and related disorders. 2024. pmc

Pain, surgery and clinical-procedure anxiety

21. Kulakaç N. et al. Effect of lavender oil on preoperative anxiety: systematic review and meta-analysis. 2024. pubmed
22. Guo P. et al. The effectiveness of aromatherapy on preoperative anxiety in adults: a systematic review and meta-analysis. 2020. pubmed
23. Ren Y. et al. Inhalation aromatherapy with lavender for postoperative pain management: a systematic review of randomised controlled trials. 2025. pubmed
24. Kritsidima M., Newton T., Asimakopoulou K. The effects of lavender scent on dental patient anxiety levels: a cluster randomised-controlled trial. 2010. pubmed
25. Zabirunnisa M. et al. Dental patient anxiety: possible deal with lavender fragrance. 2014. pubmed
26. Tabatabaeichehr M., Mortazavi H. The effectiveness of aromatherapy in the management of labour pain and anxiety: a systematic review. 2020. pubmed
27. Kaya A. et al. The effectiveness of aromatherapy in the management of labour pain and anxiety: systematic review and meta-analysis. 2023. pmc
28. Sun C. et al. The efficacy of aromatherapy on pain and anxiety during needle-related procedures in adults: systematic review and meta-analysis. 2025. pmc

Pregnancy, labour, caesarean and postpartum studies

29. Vidal-García E. et al. Efficacy of lavender essential oil in reducing stress, anxiety and improving sleep quality in pregnant women: a review. 2024. pmc
30. Mascarenhas V.H.A. et al. Effectiveness of aromatherapy on physiological and psychological symptoms during pregnancy: systematic review. 2025. sciencedirect
31. Nouira M. et al. Aromatherapy using lavender oil: effectiveness on pain and anxiety after caesarean delivery. 2024. pmc
32. Kianpour M. et al. Effect of lavender scent inhalation on prevention of stress, anxiety and depression after childbirth. 2016. pubmed
33. Kianpour M. et al. Influence of lavender oil aroma in the early hours after childbirth. 2017. pmc
34. Shamsunisha Y. et al. Aromatherapy for postpartum depression: a systematic review and meta-analysis. 2023. pmc

Skin, wound healing, inflammation and antimicrobial activity

35. Samuelson R., Lobl M., Higgins S., Clarey D., Wysong A. The effects of lavender essential oil on wound healing: a review of the current evidence. 2020. pubmed
36. Mori H.M. et al. Wound healing potential of lavender oil by acceleration of granulation and wound contraction. 2016. pmc
37. Georgantopoulos A. et al. Comparative studies on anti-inflammatory and apoptotic effects of lavender essential oil. 2023. pmc
38. Truong S., Mudgil P. The antibacterial effectiveness of lavender essential oil against methicillin-resistant Staphylococcus aureus: a systematic review. 2023. pubmed
39. Roller S. et al. Antimicrobial activity of lavender oils against methicillin-sensitive and methicillin-resistant Staphylococcus aureus. 2009. pubmed

Mechanisms and central nervous system targets

40. López V. et al. Exploring pharmacological mechanisms of lavender essential oil on central nervous system targets. Frontiers in Pharmacology. 2017. frontiersin.org
41. Schuwald A.M. et al. Lavender oil: potent anxiolytic properties via modulating voltage-dependent calcium channels. 2013. pmc
42. Malcolm B.J., Tallian K. Essential oil of lavender in anxiety disorders: ready for prime time? 2018. pmc
43. Manzoor S. et al. A comprehensive review on the anxiolytic effect of Lavandula. 2025. pmc

Safety, allergy, children and ingestion

44. Bingham L.J., Tam M.M., Palmer A.M., Cahill J.L., Nixon R.L. Contact allergy and allergic contact dermatitis caused by lavender. Contact Dermatitis. 2019. pubmed
45. DermNet. Allergic contact dermatitis to essential oils. dermnetnz.org
46. Hawkins J. et al. Prevalence of endocrine disorders among children exposed to lavender essential oil and tea tree essential oil. 2022. pubmed
47. Poison Control. Essential oils. Safety guidance on poisoning risks, ingestion and aspiration risks associated with essential oils. poison.org
48. Royal Children's Hospital Melbourne. Essential oil poisoning. Clinical guidance noting toxicity risks from essential-oil ingestion, including common household oils such as lavender. rch.org.au
49. UKTIS. Use of essential oils in pregnancy. Pregnancy-focused safety guidance on essential-oil exposure and individual risk assessment. uktis.org
50. Medicines in Pregnancy. Lavender oil. Pregnancy safety guidance noting that undiluted essential oils should not be swallowed or applied directly to the skin. medicinesinpregnancy.org